CND Life Sciences is a biotechnology company specializing in diagnostic testing for neurodegenerative diseases. Their flagship product, the Syn-One Test®, utilizes skin biopsy tissue to detect and quantify abnormal alpha-synuclein protein, a key indicator of Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and related disorders.
Leadership & Board
Current Number of Employees147
Current LinkedIn Followers4,395
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$17M
Total Amount Raised$17M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$3M
Latest Funding Amount$3M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
CND Life Sciences had 147 employees as of August 24, 2026. The number of employees increased by 0 (0.00%) week-over-week.
147Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
CND Life Sciences had 4,395 followers as of August 24, 2026. The number of followers increased by 32 (0.73%) week-over-week.
4,395Latest Followers Count
32(0.73%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.